23andMe, genetic testing
The CEO of 23andMe said there was "substantial doubt" that the company could continue to operate and said 40 percent of its ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...
The genealogy company’s CEO announced over 200 employees will be let go and it will also shutter its drug-development arm. I ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
Andme Holding Co ( (ME) ) has released its Q2 earnings. Here is a breakdown of the information 23Andme Holding Co presented to its investors.
To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. 23andMe said Monday it will lay ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback